Literature DB >> 11961239

Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma.

Jan Simák1, Karel Holada, Felice D'Agnillo, Jan Janota, Jaroslav G Vostal.   

Abstract

BACKGROUND: Blood and plasma of animals experimentally infected with transmissible spongiform encephalopathies (TSEs) can transmit TSE infection by transfusion. A conformational isoform of prion protein (PrPsc) is believed to be the TSE-infectious agent that propagates by converting the cellular prion protein (PrPc) to additional molecules of PrPsc. In orally infected animals, PrPsc accumulates in intestinal endothelial cells. In blood, two thirds of PrPc resides in plasma, but its source is not known. STUDY DESIGN AND METHODS: The expression of PrPc in cultured human umbilical vein endothelial cells (HUVECs) was studied using flow cytometry, immunoblotting, and RT-PCR. Flow cytometry was used to characterize endothelial membrane microparticles (MPs) in cell culture supernatants and in normal human plasma.
RESULTS: HUVECs and bovine aorta endothelial cells express PrPc. The number of surface PrPc molecules per cell in HUVECs was 58,000 +/- 2,800. The induction of apoptosis in HUVECs led to a marked release of membrane MPs (60,000-80,000 MPs/10(3) cells) that expressed PrPc and other endothelial antigens. The presence of endothelial cell-derived MPs expressing PrPc was demonstrated in platelet-free human plasma.
CONCLUSION: Endothelial cell apoptosis is associated with the release of PrPc-positive MPs. These MPs contribute to the PrPc pool in plasma and may have a role in disseminating TSE infectivity in blood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961239     DOI: 10.1046/j.1537-2995.2002.00072.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Authors:  Paula Saá; Oksana Yakovleva; Jorge de Castro; Irina Vasilyeva; Silvia H De Paoli; Jan Simak; Larisa Cervenakova
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

2.  Transport of prion protein across the blood-brain barrier.

Authors:  W A Banks; Sandra M Robinson; R Diaz-Espinoza; A Urayama; C Soto
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

3.  Primary blast-induced traumatic brain injury in rats leads to increased prion protein in plasma: a potential biomarker for blast-induced traumatic brain injury.

Authors:  Nam Pham; Thomas W Sawyer; Yushan Wang; Ferdous Rastgar Jazii; Cory Vair; Changiz Taghibiglou
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

4.  Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice.

Authors:  Arunima Ghosh; Wei Li; Maria Febbraio; Ricardo G Espinola; Keith R McCrae; Erin Cockrell; Roy L Silverstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

5.  Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen.

Authors:  Laura McCulloch; Karen L Brown; Barry M Bradford; John Hopkins; Mick Bailey; Klaus Rajewsky; Jean C Manson; Neil A Mabbott
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

6.  Lectin-Based Characterization of Vascular Cell Microparticle Glycocalyx.

Authors:  April K Scruggs; Eugene A Cioffi; Donna L Cioffi; Judy A C King; Natalie N Bauer
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

7.  Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study.

Authors:  Nam Pham; Hungbo Akonasu; Rhonda Shishkin; Changiz Taghibiglou
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

8.  Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.

Authors:  Monique P Gelderman; Olga Simakova; Jeffrey D Clogston; Anil K Patri; Sheena F Siddiqui; Alexander C Vostal; Jan Simak
Journal:  Int J Nanomedicine       Date:  2008

9.  Prion protein expression and processing in human mononuclear cells: the impact of the codon 129 prion gene polymorphism.

Authors:  Christiane Segarra; Sylvain Lehmann; Joliette Coste
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

10.  Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin.

Authors:  Jan Simák; Karel Holada; Jaroslav G Vostal
Journal:  BMC Cell Biol       Date:  2002-05-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.